Action of painkillers with caffeine and pain crises
Abstract
Keywords
Full Text:
PDFReferences
Benemei S, Fusi C, Trevisan G, Geppetti P. The TRPA1 channel in migraine mechanism and treatment. Br J Pharmacol. 2014;171(10):2552-67. DOI: 10.1111/bph.12512
Dodick DW. Migraine. Lancet. 2018;391(10127):1315-1330. DOI: https://doi.org/10.1016/S0140-6736(18)30478-1
Borkum JM. The Migraine Attack as a Homeostatic, Neuroprotective Response to Brain Oxidative Stress: Preliminary Evidence for a Theory. Headache. 2018;58(1):118-135. doi: 10.1111/head.13214
Rainero I, Roveta F, Vacca A, Noviello C, Rubino E. Migraine pathways and the identification of novel therapeutic targets. Expert Opin Ther Targets. 2020;24(3):245-253. doi: 10.1080/14728222.2020.1728255
Iyengar S, Johnson KW, Ossipov MH, Aurora SK. CGRP and the Trigeminal System in Migraine. Headache. 2019;59(5):659-681. doi: 10.1111/head.1352
Nowaczewska M, Wiciński M, Kaźmierczak W. The Ambiguous Role of Caffeine in Migraine Headache: From Trigger to Treatment. Nutrients. 2020;12(8):2259. doi: 10.3390/nu12082259
Burch RC, Buse DC, Lipton RB. Migraine: Epidemiology, Burden, and Comorbidity. Neurol Clin. 2019;37(4):631-649. oi: 10.1016/j.ncl.2019.06.001
Marmura MJ. Triggers, Protectors, and Predictors in Episodic Migraine. Curr Pain Headache Rep. 2018;22(12):81. doi: 10.1007/s11916-018-0734-0
Gross EC, Lisicki M, Fischer D, Sándor PS, Schoenen J. The metabolic face of migraine - from pathophysiology to treatment. Nat Rev Neurol. 2019;15(11):627-643. doi: 10.1038/s41582-019-0255-4
Renner B, Clarke G, Grattan T, Beisel A, Mueller C, Werner U, et al. Caffeine accelerates absorption and enhances the analgesic effect of acetaminophen. J Clin Pharmacol. 2007;47(6):715-26. doi: 10.1177/009127000729976
Gilmore B, Michael M. Treatment of Acute Migraine Headache. Am Fam Physician. 2011;83(3):271-280. PMID: 21302868
Mayans L, Walling A. Acute Migraine Headache: Treatment Strategies. Am Fam Physician. 2018;97(4):243-251. PMID: 29671521
Sawynok J. Caffeine and pain. Pain. 2011;152(4):726-729. doi: 10.1016/j.nrl.2014.12.016
Weiser T, Weigmann H. Effect of Caffeine on the Bioavailability and Pharmacokinetics of an Acetylsalicylic Acid-Paracetamol Combination: Results of a Phase I Study. Adv Ther. 2019;36(3):597-607. doi: 10.1007/s12325-019-0891-5
Martin VT, Vij B. Diet and Headache: Part 1. Headache. 2016;56(9):1543-1. doi: 10.1111/head.12953
Alstadhaug KB, Andreou AP. Caffeine and Primary (Migraine) Headaches-Friend or Foe? Front Neurol. 2019;10(1275):1275. doi: 10.3389/fneur.2019.01275
Shapiro RE. Caffeine and headaches. Neurol Sci. 2007;28(2):S179-83. doi: 10.1016/j.nrl.2014.12.016
Espinosa Jovel CA, Sobrino Mejía FE. Caffeine and headache: specific remarks. Neurologia. 2017;32(6):394-398. doi: 10.1016/j.nrl.2014.12.016
Lipton RB, Diener HC, Robbins MS, Garas SY, Patel K. Caffeine in the management of patients with headache. J Headache Pain. 2017;18(1):107. doi: 10.1186/s10194-017-0806-2
Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Rev. 2012;3(3):9281. doi: 10.1002/14651858.CD009281
Palmer H, Graham G, Williams K, Day R. A risk-benefit assessment of paracetamol (acetaminophen) combined with caffeine. Pain Med. 2010;11(6):951-65. doi: 10.1111/j.1526-4637.2010.00867
Borel JF, Deschaumes C, Devoize L, Huard C, Orliaguet T, Dubray C, et al. Traitement de la douleur après avulsion dentaire: essai clinique randomisé en double aveugle comparant deux formulations de paracétamol, caféine et poudre d'opium versus tramadol et placebo. Presse Med. 2010;39(5):e103-11. doi: 10.1016/j.lpm.2009.09.025
Diener HC, Peil H, Aicher B. The efficacy and tolerability of a fixed combination of acetylsalicylic acid, paracetamol, and caffeine in patients with severe headache: a post-hoc subgroup analysis from a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia. 2011;31(14):1466-76. doi: 10.1177/0333102411419682
Goldstein J, Hagen M, Gold M. Results of a multicenter, double-blind, randomized, parallel-group, placebo-controlled, single-dose study comparing the fixed combination of acetaminophen, acetylsalicylic acid, and caffeine with ibuprofen for acute treatment of patients with severe migraine. Cephalalgia. 2014;34(13):1070-8. doi: 10.1177/0333102414530527
Carvalho DS, Barea LM, Kowacs PA, Fragoso YD. Efficacy and tolerability of combined dipyrone, isometheptene and caffeine in the treatment of mild-to-moderate primary headache episodes. Expert Rev Neurother. 2012;12(2):159-67. doi: 10.1586/ern.11.193
Pini LA, Guerzoni S, Cainazzo M, Ciccarese M, Prudenzano MP, Livrea P. Comparison of tolerability and efficacy of a combination of paracetamol + caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study. J Headache Pain. 2012;13(8):669-75. doi: 10.1007/s10194-012-0484-z.
Derosier F, Sheftell F, Silberstein S, Cady R, Ruoff G, Krishen A, et al. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study. Headache. 2012;52(4):530-43. doi: 10.1111/j.1526-4610.2011.02039.x
Bjørkedal E, Flaten MA. Interaction between expectancies and drug effects: an experimental investigation of placebo analgesia with caffeine as an active placebo. Psychopharmacology (Berl). 2011;215(3):537-4. doi: 10.1007/s00213-011-2233-4
Weiser T, Weigmann H. Effect of Caffeine on the Bioavailability and Pharmacokinetics of an Acetylsalicylic Acid-Paracetamol Combination: Results of a Phase I Study. Adv Ther. 2019;36(3):597-607. doi: 10.1007/s12325-019-0891-5
Fox AW. Efficacy, end points and eventualities: sumatriptan/naproxen versus butalbital/paracetamol/caffeine in the treatment of migraine. Expert Rev Clin Pharmacol. 2012;5(5):513-6. doi: 10.1586/ecp.12.47
Weiser T, Schepers C, Mück T, Lange R. Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed-Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU as Acid or Lysinate Under Fasted and Fed Conditions-Data From 2 Single-Center, Single-Dose, Randomized Crossover Studies in Healthy Volunteers. Clin Pharmacol Drug Dev. 2019;8(6):742-753. doi: 10.1002/cpdd.672
Erol DD. The analgesic and antiemetic efficacy of gabapentin or ergotamine/caffeine for the treatment of postdural puncture headache. Adv Med Sci. 2011;56(1):25-9. The analgesic and antiemetic efficacy of gabapentin or ergotamine/caffeine for the treatment of postdural puncture headache
Aicher B, Peil H, Peil B, Diener HC. Pain measurement: Visual Analogue Scale (VAS) and Verbal Rating Scale (VRS) in clinical trials with OTC analgesics in headache. Cephalalgia. 2012;32(3):185-97. doi: 10.1177/03331024111430856
Förderreuther S, Lampert A, Hitier S, Lange R, Weiser T. The Impact of Baseline Pain Intensity on the Analgesic Efficacy of Ibuprofen/Caffeine in Patients with Acute Postoperative Dental Pain: Post Hoc Subgroup Analysis of a Randomised Controlled Trial. Adv Ther. 2020 ;37(6):2976-2987. doi: 10.1007/s12325-020-01297-y
Weiser T, Richter E, Hegewisch A, Muse DD, Lange R. Efficacy and safety of a fixed-dose combination of ibuprofen and caffeine in the management of moderate to severe dental pain after third molar extraction. Eur J Pain. 2018;22(1):28-38. doi: 10.1002/ejp.1068
Broner SW, Bobker S, Klebanoff L. Migraine in Women. Semin Neurol. 2017;37(6):601-610. doi: 10.1055/s-0037-1607393
DOI: https://doi.org/10.12957/bjhbs.2022.71635
Refbacks
- There are currently no refbacks.
Copyright (c) 2022 Brazilian Journal of Health and Biomedical Sciences